NCT04681248: Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors |
|
|
| Available | N/A | | US | DKN-01 | Leap Therapeutics, Inc. | Esophageal Neoplasm, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer, Squamous Cell Carcinoma, Gastric Adenocarcinoma, Endometrial Cancer, Uterine Cancer, Ovarian Cancer, Carcinosarcoma, Gastric Cancer | | | | |
